A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients
Clinical trial NCT00189267 · COMPLETED
Trial details
- NCT number
- NCT00189267
- Sponsor
- MEDA Pharma GmbH & Co. KG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.